��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
精星(8183)
月營收
季盈餘
2025/02/01
41.50元 (精星股價)
2025/02/01
36.24% (年增率)
466百萬元 (營收)
精星(8183) 年度營收走勢圖
精星(8183)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/02
465,622
-21.23%
341,768
36.24%
1,056,754
17.19%
114/01
591,132
-28.33%
559,952
5.57%
591,132
5.57%
113/12
824,841
-4.50%
530,896
55.37%
7,326,013
9.68%
113/11
863,706
5.07%
645,247
33.86%
6,501,172
5.74%
113/10
822,015
7.91%
660,922
24.37%
5,637,466
2.44%
113/09
761,766
19.42%
665,163
14.52%
4,815,451
-0.56%
113/08
637,882
16.77%
561,948
13.51%
4,053,685
-2.96%
113/07
546,272
0.84%
575,113
-5.01%
3,415,803
-5.52%
113/06
541,742
2.43%
514,639
5.27%
2,869,531
-5.61%
113/05
528,880
8.08%
515,601
2.58%
2,327,789
-7.83%
113/04
489,356
19.99%
509,308
-3.92%
1,798,909
-10.50%
113/03
407,833
19.33%
573,948
-28.94%
1,309,553
-12.73%
113/02
341,768
-38.96%
488,337
-30.01%
901,720
-2.69%
113/01
559,952
5.47%
438,322
27.75%
559,952
27.75%
112/12
530,896
-17.72%
595,597
-10.86%
6,679,445
-2.90%
112/11
645,247
-2.37%
644,274
0.15%
6,148,549
-2.15%
112/10
660,922
-0.64%
638,361
3.53%
5,503,302
-2.41%
112/09
665,163
18.37%
648,010
2.65%
4,842,380
-3.17%
112/08
561,948
-2.29%
614,417
-8.54%
4,177,217
-4.03%
112/07
575,113
11.75%
643,424
-10.62%
3,615,269
-3.29%
112/06
514,639
-0.19%
556,354
-7.50%
3,040,156
-1.77%
112/05
515,601
1.24%
537,914
-4.15%
2,525,517
-0.51%
112/04
509,308
-11.26%
404,088
26.04%
2,009,915
0.47%
112/03
573,948
17.53%
625,060
-8.18%
1,500,607
-6.01%
112/02
488,337
11.41%
479,828
1.77%
926,659
-4.61%
112/01
438,322
-26.41%
491,607
-10.84%
438,322
-10.84%
111/12
595,597
-7.56%
532,420
11.87%
6,878,936
52.44%
111/11
644,274
0.93%
437,854
47.14%
6,283,339
57.86%
111/10
638,361
-1.49%
424,832
50.26%
5,639,064
59.19%
111/09
648,010
5.47%
381,541
69.84%
5,000,703
60.41%
111/08
614,417
-4.51%
357,948
71.65%
4,352,693
59.09%
111/07
643,424
15.65%
307,162
109.47%
3,738,277
57.20%
111/06
556,354
3.43%
303,439
83.35%
3,094,853
49.45%
111/05
537,914
33.12%
316,174
70.13%
2,538,498
43.62%
111/04
404,088
-35.35%
341,512
18.32%
2,000,584
37.85%
111/03
625,060
30.27%
407,991
53.20%
1,596,496
43.86%
111/02
479,828
-2.40%
297,894
61.07%
971,435
38.43%
111/01
491,607
-7.67%
491,607
110/12
532,420
21.60%
4,512,644
110/11
437,854
3.07%
3,980,224
110/10
424,832
11.35%
3,542,370
110/09
381,541
6.59%
3,117,538
110/08
357,948
16.53%
2,735,997
110/07
307,162
1.23%
2,378,050
110/06
303,439
-4.03%
2,070,888
110/05
316,174
-7.42%
1,767,449
110/04
341,512
-16.29%
1,451,274
110/03
407,991
36.96%
1,109,762
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
